The charts above show that Mrk is up about 18% over the last three months and Pfe is down 8% and, at least up to now, it has been a consistent trend. You have a silly way of cherry picking a very tiny piece of data to try to convince us of possibly a turnaround in the PFE stock performance. I am not buying into it until I see at least a 3-6 month consistent increase in the Pfe stock price nor would anyone else who has a grain on sense.
========================================= Re: Milo, your bet's looking good! Already 65% of the way 13-Jun-07 08:25 pm
There's no "traditionally" about it. The past three years it just so happens there were major travesties the second half (adverse Celebrex test in 2004, the yanking of estimates in 2005 and Torcetrapib failure in 2006).
There's nothing apparent in the way of travesties in 2007. No optimistic forecasts and no huge drugs under development that could fail. Any travesty this year would have to come completely out of the blue. There would be little reason for an investor to expect any such thing.
You saw the lows this year on March 5 with the $24.70 close. Nothing resembling that will be seen. EVER!